针对自身免疫性和其他非瘤性疾病的工程T细胞免疫疗法的进展
Qiaolin Huang1, Xiaojian Zhu2, Yicheng Zhang3,4,5
1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, Hubei, China.
Biomarker research
|February 3, 2025
概括
工程T细胞显示出超出癌症治疗,自身免疫性疾病和感染的前景. 需要进一步的研究,以提高更广泛的治疗应用的安全性和有效性.
科学领域:
- 免疫学和细胞疗法.
- 生物医学研究的研究.
背景情况:
- 使用仿真抗原受体 (CAR) T 细胞进行采用免疫疗法对血液癌症有效.
- 将CAR T细胞疗法扩展到非瘤领域需要进一步的临床研究.
研究的目的:
- 审查非瘤应用工程T细胞的最新进展.
- 讨论CAR T细胞免疫治疗在各种疾病中的潜力和挑战.
主要方法:
- 临床研究和T细胞工程研究的文献综述.
- 分析CAR T细胞在自身免疫性疾病,感染,纤维化,血友病和衰老中的应用.
主要成果:
- 卡尔T细胞免疫疗法在非瘤学领域表现出积极的结果.
- 在优化扩大使用的安全性和有效性方面,仍然存在重大挑战.
结论:
- 工程T细胞为非瘤疾病提供治疗潜力.
- 持续的研究对于克服安全性和有效性的障碍以及更广泛的临床采用至关重要.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
434
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
7.8K
相关概念视频
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cell-mediated Immune Responses
66.7K
Overview
66.7K
